Nemaura Medical Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2023 12 months to Mar 31, 2023	FY2022 12 months to Mar 31, 2022	FY2021 12 months to Mar 31, 2021	FY2020 12 months to Mar 31, 2020	FY2019 12 months to Mar 31, 2019
Sales
Cost of sales
Cost of sales-inventory write down
Gross profit (loss)
Operating expenses:
Research and development
General and administrative
Impairment of intangible assets
Total operating expenses
Loss from operations
Interest income
Interest expense
Change in fair value of warrant liability
Loss before income tax benefit
Provision for income tax benefit
Net loss
Other comprehensive income:
Foreign currency translation adjustment
Comprehensive loss
Net loss per share, basic and diluted
Weighted average number of shares outstanding

Comments